Polymorphisms A1026G and G369C of CDKN1A/p21 and p53 genes in lung cancer

A. I. Dmitrieva, I. A. Kuznetsova, S. S. Rakitin, V. V. Novitskiy (Tomsk, Russian Federation)

Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Session: Lung cancer: molecular pathology and functional genomics
Session type: Poster Discussion
Number: 1961

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. I. Dmitrieva, I. A. Kuznetsova, S. S. Rakitin, V. V. Novitskiy (Tomsk, Russian Federation). Polymorphisms A1026G and G369C of CDKN1A/p21 and p53 genes in lung cancer. Eur Respir J 2011; 38: Suppl. 55, 1961

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Polymorphism in GSTM1, GSTT1, p53 and CCR5 genes and lung cancer progression: relation to p53 and Ki-67 protein expression in tumors of non-small cell lung cancer patients
Source: Eur Respir J 2006; 28: Suppl. 50, 810s
Year: 2006

Arg72Pro P53 gene polymorphism is associated with P53 mutations in non-small cell lung cancer (NSCLC) patients
Source: Eur Respir J 2004; 24: Suppl. 48, 78s
Year: 2004

Polymorphisms in cancer-related pathway genes and lung cancer
Source: Eur Respir J 2016; 48: 1184-1191
Year: 2016



p53 gene mutations in lung cancer in Korean
Source: Eur Respir J 2005; 26: Suppl. 49, 327s
Year: 2005

Evaluation of EGFR mutations and ERCC2 polymorphisms in treatment of non-small cell lung cancer
Source: Annual Congress 2005 - Chemotherapy and palliative care
Year: 2005


Arg72Pro P53 gene polymorphism as a predisposing factor for non-small cell lung cancer (NSCLC) development
Source: Eur Respir J 2004; 24: Suppl. 48, 78s
Year: 2004

Polymorphisms in the interleukin-10 gene promoter are associated with susceptibility to non-small cell lung cancer (NSCLC)
Source: Eur Respir J 2005; 26: Suppl. 49, 458s
Year: 2005

Polymorphisms in the p53 and p21 promoter are associated with susceptibility to COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 52s
Year: 2005

Functional polymorphism of p53 and CCR5 genes in lung carcinoma and bronchail asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 591s
Year: 2005

Combined effect of p53 and XRCC1 gene polymorphisms on age-associated lung cancer risk
Source: Annual Congress 2008 - Discovery of novel targets in lung disease by means of functional genomics
Year: 2008



P53 protein expression and polymorphism of GSTT1 and GSTM1 genes in central lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 191s
Year: 2006

Polymorphisms in telomere maintenance genes and risk of lung cancer
Source: Annual Congress 2009 - Pathogenesis of lung cancer
Year: 2009



Investigation of a relationship between NF-KB1A gene polymorphism and non small cell lung cancer (NSCLC)
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012

Arg72Pro and GSTM1 gene polymorphisms increase the risk of non small cell lung cancer (NSCLC)
Source: Eur Respir J 2005; 26: Suppl. 49, 92s
Year: 2005

The analysis of CHEK2 gene mutation in small cell lung cancer
Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases
Year: 2021

Analysis of XPD gene Lys751Gln polymorphism as predisposing factor for non-small cell lung cancer (NSCLC) development
Source: Eur Respir J 2007; 30: Suppl. 51, 131s
Year: 2007

Association of polymorphism of the human nm23-H1 gene (NME1) with susceptibility to and severity of non-small cell lung cancer
Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology
Year: 2007


Association of -93G®A polymorphism in the hMLH1 gene with susceptibility to and prognosis of non-small cell lung cancer in Taiwan
Source: Eur Respir J 2006; 28: Suppl. 50, 151s
Year: 2006

Investigation of survivin gene polymorphism in non-small cell lung cancer patients (NSCLC)
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012


TP53 Arg72Pro, GSTM1, GSTP1 Ile105Val and GSTT1 gene polymorphisms as predisposing factors for non-small cell lung cancer (NSCLC) development
Source: Annual Congress 2006 - Molecular pathology and genetics of lung cancer
Year: 2006